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BACKGROUND: Studies have reported some evidence of adverse eﬀects of organochlorine exposures on child development, but the results have been
inconsistent, and few studies have evaluated associations with child behavior.
OBJECTIVE: We investigated the association between prenatal and early-life exposures to 2,2 0,4,4 0,5,50-hexachlorobiphenyl (PCB-153) and 1,1-
dichloro-2,2-bis(p-chlorophenyl)-ethylene (p,p0-DDE) and behaviors in children between 5 and 9 y of age.
METHODS: In the Biopersistent organochlorines in diet and human fertility: Epidemiologic studies of time to pregnancy and semen quality in Inuit
and European populations (INUENDO) cohort, consisting of mother–child pairs from Greenland and Ukraine (n=1,018), maternal serum PCB-153
and p,p0-DDE concentrations were measured during pregnancy, and cumulative postnatal exposures during the ﬁrst 12 months after delivery were
estimated using a pharmacokinetic model. Parents completed the Strengths and Diﬃculties Questionnaire (SDQ), and children’s behaviors were
dichotomized as abnormal (high) versus normal/borderline for ﬁve SDQ subscales and the total diﬃculties score.
RESULTS: The total diﬃculties score, an overall measure of abnormal behavior, was not clearly associated with pre- or postnatal exposures to PCB-153
or to p,p0-DDE. However, pooled adjusted odds ratios (ORs) for high conduct problem scores with a doubling of exposure were 1.19 (95% CI: 0.99,
1.42) and 1.16 (95% CI: 0.96, 1.41) for pre- and postnatal PCB-153, respectively, and 1.25 (95% CI: 1.04, 1.51) and 1.24 (95% CI: 1.01, 1.51) for pre-
and postnatal p,p0-DDE, respectively. Corresponding ORs for high hyperactivity scores were 1.24 (95% CI: 0.94, 1.62) and 1.08 (95% CI: 0.81, 1.45) for
pre- and postnatal PCB-153, respectively, and 1.43 (95% CI: 1.06, 1.92) and 1.27 (95% CI: 0.93, 1.73) for pre- and postnatal p,p0-DDE, respectively.
CONCLUSION: Prenatal and early postnatal exposures to p,p 0-DDE and PCB-153 were associated with a higher prevalence of abnormal scores for con-
duct and hyperactivity at 5–9 y of age in our study population. These ﬁndings provide further support for the importance of minimizing organochlor-
ine exposures to young children and to women of childbearing age. https://doi.org/10.1289/EHP553
Introduction
Polychlorinated biphenyls (PCBs) have been widely used in, for
example, hydraulic equipment, dyes, plasticizers, capacitors, trans-
formers and ﬂame retardants. Dichlorodiphenyltrichloroethane
(DDT) has been used primarily as a pesticide and for vector con-
trol. Even though PCBs and DDT were banned from use in most
Western countries in the 1970s and 1980s, DDT continues to be
used for disease vector control in some developing countries (van
den Berg 2009), and both are persistent and ubiquitous substances
found in the environment (Ibarluzea et al. 2011).
The main exposure routes of organochlorine compounds
such as PCBs and DDT and its breakdown product dichlorodi-
phenyldichloroethylene (DDE) are through food consumption
and breastfeeding, and given their lipophilic properties and long
half-lives of 5 to 10 y, they bioaccumulate within human adi-
pose tissue (Glynn et al. 2007; Malarvannan et al. 2013; Ribas-
Fitó et al. 2005). These compounds may also cross the placental
barrier, potentially resulting in fetal exposures decades after
maternal exposure (Glynn et al. 2007; Vizcaino et al. 2014).
Environmental pollutants such as pesticides, solvents, and orga-
nochlorines may act as developmental neurotoxins, inducing
brain injury during early-life development at doses much lower
than those required for adverse eﬀects in adults, with potential
long-term implications for the child (Grandjean and Landrigan
2006; Rosas and Eskenazi 2008).
Based on concentrations measured in cord serum, prenatal
exposures to PCBs and DDE were found to be associated with
attention deﬁcit hyperactivity disorder (ADHD)-related behaviors
in 573 U.S. children at 8 y of age (Sagiv et al. 2010). Verner
et al. (2015) used a pharmacokinetic model to estimate postnatal
exposures in the same cohort and reported positive associations
between postnatal PCB exposures and ADHD-related behaviors
that were weaker than associations with prenatal exposures. PCB
concentrations in maternal blood samples were also negatively
associated with attention deﬁcit disorders in 117 German children
at 8–9 y of age (Neugebauer et al. 2015). However, other studies
have not found associations between behavior outcomes and
PCB or DDE exposures (Grandjean et al. 2012; Ribas-Fitó et al.
2007b; Strøm et al. 2014).
In the present prospective cohort study, we investigated
associations between prenatal and early-life exposures to orga-
nochlorine compounds, speciﬁcally 2,2 0,4,4 0,5,5 0-hexachlorobi-
phenyl (PCB-153) and 1,1-dichloro-2,2-bis(p-chlorophenyl)-
ethylene (p,p 0-DDE), and abnormal behavior scores among
children at 5–9 y of age.
Methods
Study Population
The study population consisted of mother–child pairs from the
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Epidemiologic studies of time to pregnancy and semen quality
in Inuit and European populations (INUENDO) birth cohort.
The target population was pregnant women attending antenatal
care visits between May 2002 and February 2004 at three hos-
pitals and eight antenatal clinics in Kharkiv, Ukraine, and at 19
local hospitals in municipalities and settlements in Greenland.
Ukraine was chosen because of recent agricultural organochlorine
pesticide use, and Greenland was chosen owing to a diet with a
high bioaccumulation of organochlorines. Furthermore, women
from Warsaw, Poland, were included in the cohort as a reference
population, but given the low participation rate at follow-up
(n=92), these women were not included in the main analyses of
this study. Women were eligible for the study if they were preg-
nant (regardless of the week of gestation), ≥18 y of age, and born
in the country where they were being recruited. Neither paternal
participation nor a successful delivery was required to be eligible
for the cohort. At baseline, 1,238 women were enrolled, with a
participation rate (out of all potentially eligible women in each re-
spective subcohort, including women who declined to provide a
blood sample) of 90% in Greenland and 26% in Ukraine. After
providing informed consent, enrolled women were interviewed
and had a venous blood sample drawn. Further details on the base-
line study population are available elsewhere (Toft et al. 2005).
A follow-up study was conducted between January 2010 and
May 2012, when the children were 5–9 y of age (Høyer et al.
2015). Parents or guardians responded to retrospective questions
concerning behavioral development and other characteristics in a
face-to-face interview or by ﬁlling in a questionnaire themselves.
Out of the women participating at baseline, the follow-up partici-
pation rate was 88% in Greenland and 77% in Ukraine. The deci-
sion to participate at both baseline and follow-up was made
without personal knowledge of the exposure levels.
Mother–child pairs that completed follow-up were included
in the present analysis if the child was a singleton birth and the
blood sample collected at enrollment was suﬃcient to measure
the exposures of interest (n=1,018). The study population was
evenly distributed between Greenland (52%) and Ukraine (48%).
Ethics
The study was approved by local ethics committees: the Ethical
Committee for Human Research in Greenland (approval no.
2010-13), and the Commission on Ethics and Bioethics Kharkiv
National Medical University in Ukraine (protocol no. 7, 7
October 2009). The storage and use of data are registered at the
Danish Data Protection Agency. All participants signed an
informed consent prior to study enrollment at baseline as well as
at follow-up.
Prenatal Exposure
The median gestational week of baseline enrollment and blood
sample collection (10th–90th percentile) was 25 (13–37) in
Greenland and 23 (9–40) in Ukraine. Cubital vein blood samples
were drawn into 10-mL vacuum tubes without additives (Becton
Dickinson) for serum collection. Sera were stored at −20C until
shipment. After arrival at the Department of Occupational and
Environmental Medicine in Lund, Sweden, sera were stored at
− 80C until analysis within one year after sample collection.
Maternal serum concentrations of PCB-153 and p,p0-DDE
were analyzed using gas chromatography–mass spectrometry fol-
lowing solid-phase extraction. PCB-153 was chosen as a proxy
for PCB exposure because it is strongly correlated with other
PCB congeners and has a long half-life in humans (DeVoto et al.
1997; Muckle et al. 2001; Ritter et al. 2011). The levels of PCB-
153 and p,p0-DDE were adjusted for lipids based on serum
concentrations of cholesterol and triglycerides determined using
enzymatic methods (Rylander et al. 2006).
The limits of detection (LODs) were 0:05 ng=mL for PCB-
153 and 0:1 ng=mL for p,p0-DDE. For PCB-153, 24 samples
were below the LOD, and for p,p0-DDE, nine samples were
below the LOD. When concentrations were below the LOD, they
were set to half of the LOD based on fresh-weight concentrations
and adjusted for lipids for all subsequent analyses. For each blood
sample, analyses were performed twice on diﬀerent days, and the
mean concentration of the two was used. If the diﬀerence
between the two samples was >30%, a third, and if necessary, a
fourth, reanalysis was performed, and the concentration was cal-
culated as a mean of two sample concentrations that met the crite-
ria. However, at sample concentrations <0:2 ng=mL, a deviation
of 0:1 ng=mL between the duplicate samples was accepted. The
relative standard deviations were calculated from samples with
concentration >LOD analyzed in duplicate on diﬀerent days
for all samples included in the original study (Jönsson et al.
2005). The total sample in the INUENDO cohort was divided
into three groups (n=990 in each group for PCB-153;
n=1,058 in each group for p,p 0-DDE). For PCB-153 (2,970
total samples), the relative standard deviations for samples in
the lowest, middle, and highest thirds of the overall distribution
were 18% (mean=0:1 ng=mL), 10% (mean=0:5 ng=mL), and
10% (mean= 2 ng=mL), respectively. For p,p 0-DDE (3,174
total samples), the corresponding relative standard deviations
were 11% (mean= 1 ng=mL), 8% (mean=3 ng=mL), and 7%
(mean= 8 ng=mL), respectively. For external quality control, the
laboratory participates in an international round-robin intercompar-
ison program. Further details on the analysis of the serum samples
can be found elsewhere (Jönsson et al. 2005).
Postnatal Exposure
We used a pharmacokinetic model developed by Verner et al.
(2013) to estimate cumulative postnatal exposures to PCB-153
and p,p0-DDE over the ﬁrst 12 months after delivery. A valida-
tion study of the pharmacokinetic model that compared predicted
values to measured serum concentrations in samples collected at
6 months of age from children enrolled in Slovakian (n=216)
and Canadian Inuit (n=150) birth cohorts reported R2 values of
0.59 and 0.81, respectively, for PCB-153, and 0.49 and 0.83,
respectively, for p,p0-DDE (Verner et al. 2013). The model inputs
used in the present study were maternal age at delivery; maternal
prepregnancy weight; duration of exclusive breastfeeding; dura-
tion of partial breastfeeding; gestational age at birth; child’s sex,
birth weight, weight and age at one or more postnatal measure-
ments, weight at the follow-up, and age at the follow-up; mater-
nal serum levels of PCB-153 and p,p0-DDE during pregnancy;
gestational age at blood sampling; and half-life of the compounds
(Verner et al. 2013). Because duration of exclusive breastfeeding
had the largest inﬂuence on the model estimates, only mother–
child pairs with available breastfeeding data and measured mater-
nal levels of PCB-153 and p,p0-DDE (n=977; 96%) were
included in the postnatal modeling.
We estimated the cumulative exposure of PCB-153 and p,p0-
DDE during the ﬁrst 12 months based on the area under the curve
for the estimates at each individual month. The model has previ-
ously been used by Høyer et al. (2014) in the same birth cohort.
The pharmacokinetic modeling was performed using acslX soft-
ware (Aegis Technologies Group, Inc.).
Outcome Assessment
We assessed behavioral development using country-speciﬁc ver-
sions of the Strengths and Diﬃculties Questionnaire (SDQ)
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administered in the local language. The SDQ is a standardized
screening tool comprising 25 questions, including both strengths
and diﬃculties, on ﬁve diﬀerent scales (emotional symptoms,
conduct problems, hyperactivity, peer relationship problems, and
prosocial behavior) (Goodman 1997). The SDQ can be applied
internationally and has been thoroughly validated in the British
population (Goodman et al. 2000; Goodman 2001). The question-
naire is used to assess the mental health of 2- to 17-y-old chil-
dren. Three response options are available for each question
(“not true,” “somewhat true,” or “certainly true,” assigned values
of 0, 1, or 2, respectively), and responses to the ﬁve questions for
each subscale are summed to derive subscale scores from 0
through 10. A high score on the prosocial scale reﬂects strengths,
whereas high scores on the other four scales indicate diﬃculties.
In addition to individual subscales, scores for the emotional, con-
duct, hyperactivity, and peer problems scales may be summed to
derive a “total diﬃculties” score ranging from 0 through 40
points. In a community sample of 9,998 British children 5–15 y
of age, Cronbach’s a for the parent-reported total diﬃculties
SDQ score was 0.82, indicating high consistency (internal valid-
ity) among the individual SDQ questions (Goodman 2001).
In the present study, parents completed the SDQ at follow-up
when the children were between 5 and 9 y of age, reﬂecting their
child’s behavior during the preceding 6 months. We used the total
diﬃculties score and the SDQ subscale according to guidelines
published by the developer of the SDQ as outcomes (Goodman
1997, 2001). The SDQ scores were categorized into normal, bor-
derline, and abnormal scores based on cut-oﬀ points (total diﬃ-
culties score: normal 0–13, borderline 14–16, abnormal 17–40;
emotional symptoms score: normal 0–3, borderline 4, abnormal
5–10; conduct problems score: normal 0–2, borderline 3, abnor-
mal 4–10; hyperactivity score: normal 0–5, borderline 6, abnor-
mal 7–10; peer problems score: normal 0–2, borderline 3,
abnormal 4–10; prosocial behavior score: normal 6–10, border-
line 5, abnormal 0–4) (Goodman 1997). We dichotomized the
individual subscale and total diﬃculties scores as abnormal ver-
sus normal or borderline using the following cut-oﬀ points from
published guidelines to deﬁne abnormal scores: total diﬃculties
score ≥17, emotional symptoms score ≥5, conduct problems
score ≥4, hyperactivity score ≥7, peer problems score ≥4, and
prosocial behavior score ≤4 (Goodman 1997).
Statistical Analyses
We derived Spearman’s correlation coeﬃcients to assess correla-
tions between prenatal and estimated postnatal PCB-153 and
p,p0-DDE concentrations. We used separate logistic regression
models to estimate associations between abnormal SDQ scores
(for individual subscales and for the total diﬃculties score, dicho-
tomized as indicated above) and each exposure (prenatal PCB-
153, postnatal PCB-153, prenatal p,p0-DDE, and postnatal p,p0-
DDE), and we performed additional sensitivity analyses using
separate sets of mutually adjusted logistic regression models that
included both prenatal PCB-153 and prenatal p,p0-DDE, or post-
natal PCB-153 and postnatal p,p0-DDE. All exposures were mod-
eled after log2 transformation such that odds ratios (ORs)
represent the relative diﬀerence in the odds of an abnormal SDQ
score associated with a doubling of exposure. The SDQ scores
of the children were dichotomized into normal and borderline
versus abnormal according to the approach described by
Goodman et al. (Goodman 1997; Goodman et al. 2000). All
analyses were performed separately for each subcohort and as
pooled analyses for both countries combined. In addition, we
report estimates from crude models (with pooled analyses
adjusted for country) and from adjusted models. We performed
complete-case analyses, such that observations with missing
covariate data were excluded.
We identiﬁed potential confounders a priori based on previ-
ous evidence of associations with behavioral outcomes in chil-
dren, associations with early-life organochlorine exposures, or
associations with both (Ellis et al. 2012; Fergusson and
Woodward 1999; Pauly and Slotkin 2008; Zahn-Waxler et al.
2008). Because we performed complete-case analyses, we also
considered the potential impact of missing data on our sample
size and power when selecting covariates. Based on these consid-
erations, we adjusted our primary models for maternal age at
birth (continuous, years), maternal smoking during the index
pregnancy (yes or no, based on serum cotinine >10 ng=mL or
≤10 ng=mL measured at enrollment in the INUENDO cohort),
child’s sex, child’s age at follow-up (continuous, years), and, for
pooled analyses, country. Our primary models of associations
with postnatal PCB and p,p0-DDE exposures were additionally
adjusted for breastfeeding duration (categorized as none,
<6months, 6–12 months, or >12months) because breastfeeding
duration has been associated with better child behavior and with
higher postnatal exposures (Mimouni-Bloch et al. 2013; Ribas-
Fitó et al. 2007a). We also performed secondary models of prena-
tal exposures after additional adjustment for breastfeeding dura-
tion because breastfeeding might act as a causal intermediate
between maternal blood levels during pregnancy and subsequent
child behaviors by inﬂuencing postnatal exposure levels.
We performed sensitivity analyses of the impact of adjusting
for additional potential confounders that were not included in the
primary model because of missing data. We used separate models
to evaluate one additional potential confounder at a time, includ-
ing parity (ﬁrst vs. second or above), maternal educational level
(left school at or before 15 y of age , left school at 16–17 y of
age, left school at 18 y of age or older), gestational age at blood
draw (continuous, weeks), and gestational age at birth (continu-
ous, weeks) because the models could not accommodate all con-
founders at once without signiﬁcant loss of power. In a
sensitivity analysis, we used the top 10th percentile of the SDQ
scores as the abnormal groups instead of the cut-oﬀ points given
by Goodman (1997) because the questionnaires were validated in
the British population and not in the Greenlandic or Ukrainian
populations; this analysis was performed within each country
speciﬁcally as well as in the pooled data. Furthermore, to assess
the excluded participants from Poland, we performed a sensitivity
analysis including Poland in the pooled analysis.
All statistical analyses were performed using Stata software
(version 14.1; StataCorp LLC). A p-value <0:05 was considered
statistically signiﬁcant.
Results
Baseline characteristics of the 1,018 mother–child pairs included
in the study are shown in Table 1. The median total diﬃculties
score was 7 in Greenland and 8 in Ukraine, and 30 Greenlandic
children (6%) and 27 Ukrainian children (5%) were classiﬁed as
having abnormal total diﬃculties scores (≥17). In Greenland,
56% of the women were classiﬁed as having smoked during preg-
nancy (based on serum cotinine >10 ng=mL at the time of enroll-
ment in the study cohort), and 11% reported that they consumed
more than seven alcoholic drinks per week when they were trying
to conceive; whereas in Ukraine, only 15% were classiﬁed as
having smoked during pregnancy, and none reported consuming
more than seven drinks per week. The women from Greenland
were more often multiparous and were slightly older than the
women from Ukraine. Further, the women from Greenland com-
pleted fewer years of school on average, and 45% breastfed their
children for >12months, compared with 22% in Ukraine. Among
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Greenlandic women, the median (10th–90th percentile) pregnancy
serum concentration was 107 ð30− 369Þ ng=g lipids for PCB-153
and 229 ð75− 954Þ ng=g lipids for p,p 0-DDE. Among Ukrainian
women, the median (10th–90th percentile) pregnancy serum
concentration was 27 ð11− 54Þ ng=g lipids for PCB-153 and
639 ð329− 1,303Þ ng=g lipids for p,p 0-DDE. The same pattern
of considerably higher levels of PCB-153 in Greenlandic
women and p,p 0-DDE in Ukrainian women was observed in the
estimated postnatal exposures.
The Spearman’s correlation coeﬃcient between PCB-153 and
p,p0-DDE was 0.92 in Greenland and 0.46 in Ukraine for the pre-
natal exposures and 0.93 in Greenland and 0.76 in Ukraine for the
postnatal exposures. In Greenland, the correlation between the pre-
natal and postnatal exposures was 0.81 for PCB-153 and 0.82 for
p,p0-DDE. In Ukraine, the correlation between the prenatal and
postnatal exposures was 0.56 for PCB-153 and 0.49 for p,p0-DDE.
Crude odds ratios for associations between the exposures and
outcomes are presented (see Table S1), and adjusted estimates
(from the primary model) are presented in Table 2. In general,
crude ORs were consistent with adjusted estimates with regard to
the direction and patterns of associations.
Prenatal PCB-153 exposures were positively associated
with abnormal conduct problem scores in both cohorts
{adjustedOR for a doubling of exposure= 1:18 [95% conﬁ-
dence interval (CI): 0.96, 1.46] based on 54 children with
abnormal scores, hereafter referred to as “cases” for conven-
ience, in Greenland; OR=1:32 (95% CI: 0.89, 1.96) based on
37 cases in Ukraine; pooled OR=1:19 (95% CI: 0.99, 1.42)}
(Table 2). Associations diﬀered between cohorts for total diﬃ-
culties scores, with a null association in the Greenland cohort
[OR=1:02 (95% CI: 0.77, 1.36); 26 cases] and nonsigniﬁcant
positive associations in the Ukraine cohort [OR=1:24 (95%
CI 0.77, 1.99); 25 cases] and in the pooled population
[OR=1:09 (95% CI 0.86, 1.38)]. ORs also varied between the
cohorts for prenatal PCB-153 exposure and abnormal hyperac-
tivity scores, with a nonsigniﬁcant positive association in the
Greenland cohort (19 cases), a null association in the Ukraine
cohort (22 cases), and a nonsigniﬁcant positive association
overall [OR=1:24 (95% CI: 0.94, 1.62)]. Associations between
prenatal PCB-153 exposure and other outcomes were essentially
null.
Patterns of results for estimated postnatal PCB-153 exposure
were similar to those for prenatal PCB-153 exposure for conduct
scores [nonsigniﬁcant positive associations for both subcohorts,
pooledOR for a doubling of exposure = 1:16 (95% CI: 0.96, 1.41)]
and abnormal total diﬃculties scores (nonsigniﬁcant associations
Table 1. Characteristics of mothers and their children.
Characteristic Greenland (n=525) Ukraine (n=493) Pooled (n=1,018)
Exposure [median (10th–90th percentile)]
Pregnancy serum PCB-153 (ng/g lipids) 107 (30–369) 27 (11–54) 45 (15–253)
Estimated postnatal PCB-153 (ng/g lipids) 2647 (558–9,618) 516 (104–1,419) 1001 (173–6,368)
Pregnancy serum p,p 0-DDE (ng/g lipids) 299 (75–954) 639 (329–1,303) 465 (124–1,158)
Estimated postnatal p,p 0-DDE (ng/g lipids) 7075 (1,282–23,133) 12,459 (2,914–34,724) 9642 (1,836–28,807)
Outcome [median score (number of children with abnormal scoresa)]
Total difficulties (score 0 to 40) 7 (30) 8 (27) 7 (57)
Emotional problems (score 0 to 10) 1 (44) 1 (26) 1 (70)
Conduct problems (score 0 to 10) 1 (58) 1 (40) 1 (98)
Hyperactivity (score 0 to 10) 2 (23) 3 (24) 3 (47)
Peer problems (score 0 to 10) 2 (113) 2 (69) 2 (182)
Prosocial behavior (score 0 to 10) 6 (65) 6 (51) 6 (116)
Maternal characteristics
Maternal age at delivery (y), median (10th–90th percentile) 26 (20–36) 24 (19–32) 25 (20–35)
Parity, n (%)
1st 166 (33) 402 (82) 568 (57)
2nd or above 335 (67) 91 (18) 426 (43)
Smoking during pregnancy,b n (%)
Yes (serum cotinine >10 ng=mL) 295 (56) 75 (15) 370 (37)
No (serum cotinine ≤10 ng=mL) 230 (44) 413 (84) 643 (63)
Alcohol consumption when trying to conceive, n (%)
≤7 drinks per week 465 (89) 493 (100) 958 (94)
>7 drinks per week 60 (11) 0 (0) 60 (6)
Educational level, left school at age (y), n (%)
≤15 44 (10) 25 (6) 69 (8)
16–17 169 (36) 116 (27) 285 (32)
≥18 251 (54) 293 (67) 544 (60)
Child characteristics
Sex, n (%)
Male 284 (54) 261 (53) 545 (54)
Female 239 (46) 229 (47) 468 (46)
Age at follow-up (y), median (10th–90th percentile) 8 (7–9) 7 (7–8) 7 (7–9)
Total breastfeeding duration (months), n (%)
0 18 (4) 42 (9) 60 (6)
<6 120 (25) 165 (34) 285 (30)
6–12 124 (26) 175 (36) 299 (31)
>12 213 (45) 108 (22) 321 (33)
Gestational age at blood sample (weeks),median (10th–90th percentile) 25 (13–37) 23 (9–40) 24 (10–39)
Gestational age at birth (weeks), n (%)
≥37weeks 498 (95) 481 (98) 979 (97)
<37weeks 25 (5) 9 (2) 34 (3)
Note: PCB-153, 2,2 0,4,4 0 ,5,5 0-hexachlorobiphenyl; p,p 0-DDE, 1,1-dichloro-2,2-bis(p-chlorophenyl)-ethylene.
aTotal difficulties score: abnormal ≥17; Emotional Symptoms Score: abnormal ≥5; Conduct Problems Score: abnormal ≥4; Hyperactivity Score: abnormal ≥7; Peer Problems Score:
abnormal ≥4; Prosocial Behavior Score: abnormal ≤4.
bYes or no, based on serum cotinine >10 ng=mL or ≤10 ng=mL measured at enrollment.
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that were negative for Greenland, positive for Ukraine, and close
to the null overall) (Table 2). In addition, postnatal PCB-153 expo-
sures were positively associated with abnormal peer relationship
scores in Ukraine [OR=1:51 (95% CI: 1.11, 2.04); 64 cases] but
were null for Greenland (81 cases), resulting in a pooled OR of
1.12 (95% CI: 0.97, 1.30).
Prenatal p,p0-DDE exposure was positively associated with
abnormal scores in both cohorts for conduct [pooledOR for
a doubling of exposure= 1:25 (95% CI: 1.04, 1.51); 54 Greenland
cases and 37 Ukraine cases], hyperactivity [pooledOR=1:43
(95% CI: 1.06, 1.92), 19 Greenland cases and 22 Ukraine
cases], and, to a lesser extent, peer relationship problems
[pooledOR=1:12 (95% CI: 0.97, 1.29); 92 Greenland cases and
66 Ukraine cases] (Table 2). Associations with prenatal p,p0-DDE
exposure diﬀered between the subcohorts for abnormal total diﬃ-
culties and emotional scores (nonsigniﬁcant positive associations in
Ukraine and null or negative associations in Greenland) and abnor-
mal prosocial scores (positive for Greenland, null for Ukraine).
Associations with estimated postnatal p,p0-DDE exposure
were generally consistent with those for prenatal p,p0-DDE expo-
sure, with regard to both patterns of associations by subcohort and
the estimated ORs, with positive subcohort and pooled ORs for
abnormal conduct, hyperactivity, and peer relation scores (Table
2). As was the case for associations with prenatal p,p0-DDE expo-
sure, ORs for estimated postnatal p,p0-DDE exposure and abnor-
mal total diﬃculties and emotional scores were also positive for
Ukraine and null for Greenland, whereas ORs for abnormal proso-
cial scores were positive for Greenland and null for Ukraine.
When including both PCB-153 and p,p0-DDE in the models,
the conﬁdence intervals were wider and the overall associations
with PCB-153 were attenuated, whereas the p,p0-DDE associa-
tions were enhanced in some cases, thus making it diﬃcult to
determine whether diﬀerences were simply the result of reduced
precision, confounding by coexposure to each pollutant, or both
(see Table S2).
We performed secondary analyses that adjusted for parity,
maternal educational level, breastfeeding duration, gestational
age at blood draw, and gestational age at birth. Including these
covariates only changed the estimates marginally, and none of
these covariates changed the signiﬁcance level of the studied
associations (data not shown).
Primary models of associations between prenatal exposures
and behavioral outcomes were not adjusted for breastfeeding du-
ration, which might act as an intermediate between prenatal expo-
sures (maternal serum levels) and the outcomes by inﬂuencing
postnatal exposures. Estimates from models of prenatal exposures
that were additionally adjusted for breastfeeding duration (0,
<6months, 6–12 months, >12months) were similar to those
from the main analysis for the Ukraine cohort, whereas in the
Greenland cohort, ORs were slightly attenuated toward the null
(see Table S3). This result might reﬂect cohort-speciﬁc mediation
by breastfeeding, but it might also be related to missing data for
breastfeeding duration, which eliminated 40 observations for
Greenland, but only 3 observations for Ukraine, from the adjusted
complete-case analysis models. In the sensitivity analysis using
the top 10th percentile of the SDQ scores as the abnormal group,
Table 2. Adjusted odds ratios (95% confidence intervals) for abnormala behavior scores associated with a doubling of prenatal and postnatal PCB-153 and
p,p 0-DDE.
Outcome
Greenland Ukraine Pooledb
n cases n total
Adjusted OR
(95% CI)c n cases n total
Adjusted OR
(95% CI)c n cases n total
Adjusted OR
(95% CI)c
Prenatal PCB-153
Total difficulties 26 452 1.02 (0.77, 1.36) 25 456 1.24 (0.77, 1.99) 51 908 1.09 (0.86, 1.38)
Emotional 37 454 0.88 (0.70, 1.11) 23 456 1.16 (0.71, 1.90) 60 910 0.94 (0.76, 1.15)
Conduct 54 454 1.18 (0.96, 1.46) 37 456 1.32 (0.89, 1.96) 91 910 1.19 (0.99, 1.42)
Hyperactivity 19 452 1.35 (0.96, 1.89) 22 456 0.96 (0.60, 1.53) 41 908 1.24 (0.94, 1.62)
Peer 92 453 1.04 (0.88, 1.22) 66 456 1.19 (0.88, 1.61) 158 909 1.05 (0.92, 1.21)
Prosocial 51 453 1.17 (0.94, 1.45) 47 456 0.83 (0.59, 1.16) 98 909 1.06 (0.89, 1.26)
Postnatal PCB-153
Total difficulties 19 412 0.90 (0.65, 1.25) 24 449 1.30 (0.81, 2.10) 43 861 1.06 (0.82, 1.38)
Emotional 31 414 0.87 (0.67, 1.12) 22 449 1.16 (0.70, 1.91) 53 863 0.94 (0.75, 1.17)
Conduct 46 414 1.14 (0.91, 1.42) 36 449 1.24 (0.84, 1.83) 82 863 1.16 (0.96, 1.41)
Hyperactivity 15 412 1.05 (0.72, 1.53) 21 449 1.03 (0.64, 1.66) 36 816 1.08 (0.81, 1.45)
Peer 81 413 1.03 (0.86, 1.22) 64 449 1.51 (1.11, 2.04) 145 862 1.12 (0.97, 1.30)
Prosocial 43 413 1.16 (0.92, 1.45) 46 449 0.88 (0.64, 1.22) 89 862 1.06 (0.89, 1.28)
Prenatal p,p 0-DDE
Total difficulties 26 452 1.09 (0.82, 1.45) 25 456 1.46 (0.87, 2.44) 51 908 1.15 (0.90, 1.48)
Emotional 37 454 0.94 (0.76, 1.17) 23 456 1.24 (0.71, 2.15) 60 910 0.97 (0.79, 1.19)
Conduct 54 454 1.24 (1.00, 1.54) 37 456 1.58 (1.02, 2.44) 91 910 1.25 (1.04, 1.51)
Hyperactivity 19 452 1.36 (0.95, 1.94) 22 456 1.42 (0.84, 2.40) 41 908 1.43 (1.06, 1.92)
Peer 92 453 1.11 (0.94, 1.30) 66 456 1.36 (0.96, 1.91) 158 909 1.12 (0.97, 1.29)
Prosocial 51 453 1.24 (1.00, 1.54) 47 456 0.99 (0.66, 1.47) 98 909 1.16 (0.97, 1.39)
Postnatal p,p 0-DDE
Total difficulties 19 412 1.02 (0.74, 1.41) 24 449 1.51 (0.93, 2.45) 43 861 1.16 (0.88, 1.52)
Emotional 31 414 0.97 (0.76, 1.23) 22 449 1.23 (0.73, 2.08) 53 863 1.00 (0.80, 1.25)
Conduct 46 414 1.21 (0.96, 1.52) 36 449 1.42 (0.93, 2.18) 82 863 1.24 (1.01, 1.51)
Hyperactivity 15 412 1.11 (0.76, 1.60) 21 449 1.50 (0.90, 2.52) 36 861 1.27 (0.93, 1.73)
Peer 81 413 1.10 (0.93, 1.31) 64 449 1.79 (1.28, 2.50) 145 862 1.20 (1.03, 1.40)
Prosocial 43 413 1.28 (1.01, 1.61) 46 449 1.03 (0.70, 1.49) 89 862 1.20 (0.99, 1.45)
Note: CI, confidence interval; DDE, dichlorodiphenyldichloroethylene; OR, odds ratio; PCB-153, 2,2 0 ,4,4 0,5,5 0-hexachlorobiphenyl; p,p 0-DDE, 1,1-dichloro-2,2-bis(p-chlorophenyl)-
ethylene.
aTotal difficulties score: abnormal ≥17; Emotional Symptoms Score: abnormal ≥5; Conduct Problems Score: abnormal ≥4; Hyperactivity Score: abnormal ≥7; Peer Problems Score:
abnormal ≥4; Prosocial Behavior Score: abnormal ≤4.
bOR for the pooled cohort is adjusted for country.
cAdjusted for maternal age (continuous, years), maternal smoking during pregnancy (categorical, yes/no, based on serum cotinine >10 ng=mL or ≤10 ng=mL), child’s sex (categorical,
boy/girl), and child’s age at follow-up (continuous, years). Estimated postnatal PCB-153 and p,p 0-DDE are additionally adjusted for breastfeeding duration (categorical, >6months,
6–12 months, or >12months).
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the overall pattern of the results did not change (see Table S4). In
addition, including the excluded participants from Poland in the
pooled analysis did not change the results (see Table S5).
Discussion
We found a consistent association between a doubling of prenatal
exposure to p,p0-DDE and increased odds of conduct problems in
Greenland and Ukraine as well as in the pooled analysis. In addi-
tion, postnatal p,p0-DDE exposure was associated with conduct
problems in the pooled analysis. Prenatal and postnatal p,p0-DDE
exposures were positively associated with abnormal hyperactivity
scores in both cohorts (signiﬁcant for the pooled prenatal expo-
sure OR), as well as with abnormal peer relationship scores (sig-
niﬁcant for the pooled postnatal exposure OR). In addition, we
estimated nonsigniﬁcant positive associations with abnormal con-
duct scores in both cohorts for prenatal and postnatal PCB-153
exposures. The associations with total diﬃculties scores were not
signiﬁcant.
Our ﬁndings suggest that prenatal and postnatal exposures to
p,p0-DDE and potentially prenatal expsure to PCB-153 may
increase the risk or prevalence of conduct problems and abnormal
hyperactivity in children 5 to 9 y of age. These ﬁndings add to
the growing body of evidence of adverse developmental eﬀects
of in utero exposure to neurotoxins such as PCBs and DDE
(Grandjean and Landrigan 2014). In a cohort of 573 mother–child
pairs from Massachusetts, Sagiv et al. (2010) reported an associa-
tion between umbilical cord serum levels of four PCB congeners
[median (5th–95th percentile): 0:19 ð0:01, 4:41Þ ng=g] and DDE
[median (5th–95th percentile): 0:31 ð0:00, 14:93Þ ng=g]; they also
reported ADHD-like symptoms in children at 8 y of age meas-
ured with the Conners’ Rating Scale for Teachers (CRS-T).
Those results are generally consistent with our ﬁndings for prena-
tal p,p0-DDE exposures, although abnormal hyperactivity scores
were associated with prenatal PCB-153 exposures in only one of
the two cohorts included in our analysis. In the same cohort,
Verner et al. (2015) found associations between ADHD-related
behavior (assessed by the CRS-T) and estimated postnatal PCB
exposure for the ﬁrst 12 months after delivery calculated using a
pharmacokinetic model. In our study, we used the same pharma-
cokinetic model (Verner et al. 2013) to calculate postnatal expo-
sure to PCB-153 and p,p0-DDE, and we observed that exposure–
outcome associations similarly tended to be attenuated when
comparing postnatal exposures with prenatal exposures. Another
study found that maternal whole blood levels of three PCB con-
geners [arithmetic mean (SD): 0:19 ð0:18Þ lg=g lipid] were asso-
ciated with lowered attention function in a German birth cohort,
but the number of participants was small (n=117) (Neugebauer
et al. 2015).
However, studies have also reported null ﬁndings for associa-
tions between PCBs, DDE, and behavior in children. Grandjean
et al. (2012) studied a cohort of 917 seven-year-old children from
the Faroe Islands and reported that attention [based on a
Continuous Performance Test (CPT)] was positively associated
with cord blood levels of DDE but was not clearly associated with
the sum of four PCB congeners (geometricmean= 1:86 lg=L;
interquartile range: 2 lg=L). This ﬁnding is in contrast to those of
our study, which showed a positive association between prenatal
and postnatal p,p0-DDE exposures and abnormal hyperactivity
scores. Nevertheless, it is diﬃcult to compare the studies given the
diﬀerent outcome ascertainment methods and behavioral aspects
(i.e., attention vs. behavior) and the diﬀerent exposure assessments
(i.e., measured in maternal serum vs. cord blood). In a Danish
cohort of 872 pregnant women, the sum of six PCB congeners
[median (interquartile range): 9:2 ð5:3Þ pmol=mL] and DDE [me-
dian (interquartile range): 2:5 ð2:2Þ ng=mL] was measured in
serum between 1988 and 1989, and the children were followed up
through national registers until 2011 for diagnosis or prescription
of medication for ADHD (Strøm et al. 2014). The study showed
no association between prenatal exposure to PCB or DDE and
ADHD (Strøm et al. 2014). These results, in which the outcome
was ADHD medication and ADHD diagnosis of children followed
up beyond childhood, are diﬃcult to compare with those of our
study, where behavioral symptoms, including hyperactivity and
conduct problem dimensions, were reported by parents for chil-
dren between 5 and 9 y of age. A follow-up of two Spanish birth
cohorts (n=391) showed an association between hexachloroben-
zene and adverse social competences and ADHD-like behavior,
but the investigators found no association for cord blood levels of
PCB (concentration not given) and DDE (concentration not given)
(Ribas-Fitó et al. 2007b). On the basis of the existing literature, it
is diﬃcult to draw a clear conclusion about the eﬀects of the com-
pounds on child behavior given the limited number of studies and
because not all studies are directly comparable. Diﬀerences may
be due to diﬀerent rating scales; ages of the children at assessment;
ages of the mothers; exposure levels; measured congeners; mea-
surement error; whether the compounds were tested in cord blood,
serum, or placental tissue; potential inﬂuence of uncontrolled con-
founding; and diﬀerences in susceptibility among populations.
The possible biological mechanisms behind behavioral distur-
bances and early-life exposure to PCBs and DDE are still
unknown. However, studies have shown an association between
the compounds and altered thyroid function. Herbstman et al.
(2008) found an association between cord blood levels of six
PCB congeners and lowered total thyroxin levels in infants born
by spontaneous vaginal delivery. Similarly, Julvez et al. (2011)
found an association for cord blood levels of four PCB congeners
and p,p0-DDE with lowered resin triiodothyronine uptake ratio (a
proxy of the binding capacity of thyroxine-binding globulin re-
sponsible for carrying thyroid hormones in the bloodstream).
Altered thyroid function may aﬀect development of the fetal
brain (Morreale de Escobar et al. 2004). Furthermore, it has also
been suggested that PCBs might aﬀect neurodevelopment
through diverse mechanisms related to endocrine disruption (Bell
2014). In addition, animal studies have shown that PCBs can alter
the dopaminergic levels in the brain, which may lead to cognitive
and behavioral impairment of the fetus during pregnancy
(Arnsten 1997; Caudle et al. 2006; Seegal et al. 1997, 2002).
This study has some limitations. Participation rates at baseline
were 90% in Greenland and 26% in Ukraine, and although a non-
response analysis at baseline showed almost no diﬀerence in age
or parity among participants and nonparticipants in either cohort
(Toft et al. 2005), we cannot rule out selection bias. A commonly
stated reason for nonparticipation among women from Ukraine
was a concern that collection of the blood sample might be harm-
ful to the fetus. The decision to participate at both baseline and
follow-up was made without knowledge of the prenatal or post-
natal exposure levels.
Blood samples were collected throughout pregnancy, mainly
in the second and third trimesters. Because PCBs and DDE tend
to decrease throughout pregnancy, exposure misclassiﬁcation
might occur (Adetona et al. 2013; Glynn et al. 2011). We
addressed this possibility in a sensitivity analysis adjusting for
gestational age at blood sampling, which did not change the
results (data not shown). For that reason, diﬀerences in gesta-
tional age at blood sampling do not seem to be of major concern.
In addition, we had no measurements of the postnatal expo-
sure to PCB-153 and p,p0-DDE and used a pharmacokinetic
model to estimate the cumulative exposure in the ﬁrst 12 months
after delivery. The model has been validated in a similar setting
(Verner et al. 2013) and has previously been used in the same
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birth cohort (Høyer et al. 2014). Nevertheless, exact measures of
the postnatal exposures would have been preferable.
As the outcome measure, we used the SDQ, which can be
applied internationally and has been thoroughly validated in the
British population (Goodman et al. 2000; Goodman 2001). The
SDQ is not a diagnostic tool, but it can be used as a screening
tool to assess the mental health of children as both a total score
and on ﬁve diﬀerent subscales.
Because SDQ cut-oﬀ points were not validated in the
Greenlandic and Ukrainian populations, we used the general cut-
oﬀ points given by Goodman (1997) for the British population,
which could lead to misclassiﬁcation of the outcome estimate. We
addressed this possibility in a sensitivity analysis using the top
10th percentile as the cut-oﬀ, which did not alter the results con-
siderably. Furthermore, studies have provided evidence of useful
psychometric properties of the SDQ across diﬀerent Nordic coun-
tries including Sweden, Finland, Norway, Denmark, and Iceland
(Obel et al. 2004), and to some extent in countries beyond Europe,
including Brazil, Yemen, and Australia (Woerner et al. 2004).
Analyses were repeated using two-pollutant models that were
mutually adjusted for PCB-153 and p,p0-DDE during the same
time period. As expected, estimates were less precise when the
highly correlated exposures were included in the same model.
However, associations with p,p0-DDE were generally consistent
with the primary model estimates after adjustment for PCB-153,
whereas associations with PCB-153 were somewhat more likely
to be attenuated when adjusted for coexposure to p,p0-DDE.
The proportions of participants classiﬁed as having abnormal
total diﬃculties scores (6% in Greenland and 5% in Ukraine)
were consistent with expectations (Elberling et al. 2010;
Goodman et al. 2000), but the absolute numbers of children clas-
siﬁed were small (30 in Greenland and 27 in Ukraine with abnor-
mal total diﬃculties scores among children included in the
study). In addition to limiting the precision of our estimates, this
also limited our ability to adjust for potential confounders, partic-
ularly those with missing data for some study participants. To
ensure suﬃcient power in relation to the number of missing val-
ues, we chose to adjust our main analysis only for maternal age at
birth, maternal smoking during pregnancy, child’s sex, and
child’s age at follow-up. Other covariates such as parity, maternal
educational level, gestational age at blood sampling, and gesta-
tional age at birth were addressed in secondary analyses and did
not change the estimate substantially (data not shown).
The strengths of our study include the prospective follow-up
design. The follow-up period of 5 to 9 y enabled us to estimate
associations of early-life exposures with behavioral outcomes in
school-age children. In addition, the study population of mother–
child pairs from Greenland and Ukraine enabled us to evaluate
the consistency of exposure–outcome associations across diﬀer-
ent regions and exposure contrasts. Despite diﬀerences between
Greenland and Ukraine regarding baseline characteristics (mater-
nal age at delivery, parity, maternal educational level, alcohol
consumption at the time of conception, smoking during preg-
nancy, and breastfeeding duration) and diﬀerences in exposure
levels, remarkably similar associations between organochlorine
exposures and behavior outcomes, measured as total diﬃculties
as well as conduct and hyperactivity problems, were observed in
results stratiﬁed by country.
Conclusion
We found no clear association between total diﬃculties scores
and either prenatal or postnatal exposure to PCB-153 or p,p0-
DDE. However, for the subscale scores, the results of this study
indicated that prenatal and postnatal exposure to p,p0-DDE may
increase the risk of conduct problems and, to some extent, the
risk of hyperactivity in children at 5 to 9 y of age. Associations
were less consistent for prenatal and postnatal PCB-153 expo-
sures; nevertheless, we found a nonsigniﬁcant positive associa-
tion for abnormal conduct scores in both cohorts. Our ﬁndings
provide evidence that in utero exposure to organochlorines such
as PCBs and DDE may contribute to adverse behavioral develop-
ment and emaphasize the importance of minimizing organochlor-
ine exposures to children and to women of childbearing age.
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